EUVIMEDEUVIMED entdecken
Open Access

Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy

Stephanie M Stanford iD, Tiffany P Nguyen iD, Joseph Chang iD, Zixuan Zhao, G Lavender Hackman iD, Eugenio Santelli iD, Colton M Sanders iD, Madhusudhanarao Katiki iD, Eleonora Dondossola iD, Brooke L Brauer, Michael A Diaz iD, Yuan Zhan iD und 14 weitere

Science Advances · 02.02.2024 · 10 (5)

DOI: 10.1126/sciadv.adg7887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 02.02.2024. Verfasst von Stephanie M Stanford und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Diego, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein tyrosine phosphatases (PTPs) play major roles in cancer and are emerging as therapeutic targets. Recent reports suggest low–molecular weight PTP (LMPTP)—encoded by the ACP1 gene—is overexpressed in prostate tumors. We found ACP1 up-regulated in human prostate tumors and ACP1 expression inversely correlated with overall survival. Using CRISPR-Cas9–generated LMPTP knockout C4-2B and MyC-CaP cells, we identified LMPTP as a critical promoter of prostate cancer (PCa) growth and bone metastasis. Through metabolomics, we found that LMPTP promotes PCa cell glutathione synthesis by dephosphorylating glutathione synthetase on inhibitory Tyr 270 . PCa cells lacking LMPTP showed reduced glutathione, enhanced activation of eukaryotic initiation factor 2–mediated stress response, and enhanced reactive oxygen species after exposure to taxane drugs. LMPTP inhibition slowed primary and bone metastatic prostate tumor growth in mice. These findings reveal a role for LMPTP as a critical promoter of PCa growth and metastasis and validate LMPTP inhibition as a therapeutic strategy for treating PCa through sensitization to oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMaleHumansMiceAnimalsMolecular WeightTyrosineProtein Tyrosine Phosphatases

Substanzen

TyrosineProtein Tyrosine Phosphatases

Autor:innen und Institutionen

  • Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Department of Nutritional Sciences, College of Natural Sciences and Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
  • Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Department of Genitourinary Medical Oncology and David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

ORCID-Profile: Stephanie M Stanford, Tiffany P Nguyen, Joseph Chang, G Lavender Hackman, Eugenio Santelli, Colton M Sanders, Madhusudhanarao Katiki, Eleonora Dondossola, Michael A Diaz, Yuan Zhan, Philip A Watson, Banumathi Sankaran, Vanessa Parietti, Antonios G Mikos, Alessia Lodi, Andrew Elliott, Ramachandran Murali, Stefano Tiziani, Arminja N Kettenbach, Nunzio Bottini

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Stanford, S. M., Nguyen, T. P., Chang, J., Zhao, Z., Hackman, G. L., Santelli, E., Sanders, C. M., Katiki, M., Dondossola, E., Brauer, B. L., Diaz, M. A., Zhan, Y., Ramsey, S. H., Watson, P. A., Sankaran, B., Paindelli, C., Parietti, V., Mikos, A. G., Lodi, A., …, & Bottini, N. (2024). Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy. Science Advances, 10(5). https://doi.org/10.1126/sciadv.adg7887

Vancouver

Stanford SM, Nguyen TP, Chang J, Zhao Z, Hackman GL, Santelli E, et al. Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy. Science Advances. 2024;10(5). doi:10.1126/sciadv.adg7887

BibTeX
@article{Stanford2024,
  author = {Stanford, Stephanie M and Nguyen, Tiffany P and Chang, Joseph and Zhao, Zixuan and Hackman, G Lavender and Santelli, Eugenio and Sanders, Colton M and Katiki, Madhusudhanarao and Dondossola, Eleonora and Brauer, Brooke L and Diaz, Michael A and Zhan, Yuan and Ramsey, Sterling H and Watson, Philip A and Sankaran, Banumathi and Paindelli, Claudia and Parietti, Vanessa and Mikos, Antonios G and Lodi, Alessia and Bagrodia, Aditya and Elliott, Andrew and McKay, Rana R and Murali, Ramachandran and Tiziani, Stefano and Kettenbach, Arminja N and Bottini, Nunzio},
  title = {Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {5},
  doi = {10.1126/sciadv.adg7887}
}
Kostenlos starten →